Biopharmx Corp (NYSEAMERICAN:BPMX)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $0.19, but opened at $0.19. Biopharmx shares last traded at $0.18, with a volume of 5450 shares traded.
Biopharmx (NYSEAMERICAN:BPMX) last posted its quarterly earnings results on Thursday, August 30th. The biotechnology company reported ($0.02) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.02). The firm had revenue of $0.02 million during the quarter, compared to the consensus estimate of $0.02 million.
In other news, Director Anja B. Krammer sold 500,000 shares of the business’s stock in a transaction on Friday, October 12th. The shares were sold at an average price of $0.19, for a total value of $95,000.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Biopharmx Company Profile (NYSEAMERICAN:BPMX)
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).
Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.